A method of treating skin is disclosed. The method can include topically applying to a peron's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.

The present invention relates to a composition comprising arginine, at least one silicate, at least one alkanolamine, and optionally aqueous ammonia and/or at least one compound which generates aqueous ammonia. The composition further comprises at least one thickening agent chosen from non-associative cellulose polymers, anionic associative polymers, non-ionic associative polymers, and their mixtures. The invention also relates to a method for the treatment of keratin fibres, in particular human keratin fibres, such as the hair, comprising the application of at least one composition according to the invention; and also to the use of the composition according to the invention for the treatment of said keratin fibres, and in particular for the oxidation dyeing and/or the bleaching of the latter.

The present invention relates to an isotropic concentrate composition that is easy to hydrate and transform into an end use wash composition. The end use wash composition resulting from the concentrate composition is suitable for topical application and for hand washing. The concentrate comprises fragrance oil and emulsifier at levels that unexpectedly result in a concentrate composition and end use composition that are free of ingredient precipitation that interferes with the appearance and usage of the compositions.

The present invention is directed to a method for producing advantageous microcapsules. Moreover, the present invention provides microcapsules obtained/obtainable by the method according to the invention.

Provided is a cosmetic comprising nano bubble-liquid and cosmetic ingredients. The cosmetic according to the present invention comprises nano bubble-liquid and cosmetic ingredients, in which the nano bubble-liquid is liquid in a nano bubble state comprising a liquid medium and bubbles, the bubbles having a diameter of 5 nm to 500 nm.

Provided is a cosmetic comprising nano bubble-liquid and cosmetic ingredients. The cosmetic according to the present invention comprises nano bubble-liquid and cosmetic ingredients, in which the nano bubble-liquid is liquid in a nano bubble state comprising a liquid medium and bubbles, the bubbles having a diameter of 5 nm to 500 nm.

Solid cleansing compositions and methods for the same are disclosed herein. The solid cleansing composition may include a soap and a plant oil. The plant oil may include flaxseed oil, and may be present in an amount effective to maintain or increase hydration of skin, inhibit inflammation of skin, deodorize skin, inhibit irritation of skin, or combinations thereof.

Disclosed are alcohol-free personal care compositions, e.g., hand sanitizers, that effectively deposit topically active natural antibacterial compounds (e.g., carvone and thymol) on the skin. In one aspect the disclosure relates to personal care compositions comprising, essential oils (e.g., thymol and carvone), in combination with a carboxylic acid, (e.g., lactic acid), into an alcohol-free product that leads to unexpected benefits with respect to bacterial reduction, e.g., with respect to reduction of S. aureus and E. coli bacteria.

Disclosed herein are oral care compositions comprising hydroxyapatite and a silica abrasive as well as methods of reducing or inhibiting enamel erosion, repairing enamel erosion damage, increasing enamel microcrack resistance and/or increasing enamel microscratch resistance using these compositions.

Methods of inhibiting the growth of Porphyromonas gingivalis (“P. gingivalis”) in the oral cavity using cannabinoid compounds are described herein. The cannabinoid compounds can include one or more of cannabinol cannabigerol (“CBG”), cannabigerolic acid (“CBGA”), cannabidiolic acid (“CBDA”), and (+)-cannabidiol (“((+)-CBD”), cannabichromene (“CBC”), cannabinol (“CBN”), cannabidivarin (“CBDV”), cannabidol (“CBD”), cannabidol-C.sub.4 (“CBD-C.sub.4”), cannabigerivarin (“CBGV”), cannabigerol butyl (“CBG-C4”), cannabichromenic acid (“CBCA”), cannabicyclolic acid (“CBLA”), and cannabinolic acid (“CBNA”), cannabidol-C.sub.2 (“CBD-C.sub.2”) and cannabigerolic acid butyl (“CBGA-C4”). The methods can be used to treat or prevent periodontal disease. Compositions and articles including the cannabinoid compounds are further disclosed.